CA
MRK icon

Crumly & Associates’s Merck MRK Stock Holding History

Crumly & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
9,224
+1,993
+28% +$233K 0.23% 67
2026
Q1 		$870K Buy
7,231
+280
+4% +$32.3K 0.18% 78
2025
Q4 		$732K Sell
6,951
-2,491
-26% -$234K 0.15% 88
2025
Q3 		$792K Buy
9,442
+1,520
+19% +$125K 0.17% 81
2025
Q2 		$627K Sell
7,922
-295
-4% -$23.4K 0.15% 83
2025
Q1 		$738K Buy
8,217
+1,260
+18% +$118K 0.2% 71
2024
Q4 		$692K Sell
6,957
-1,333
-16% -$137K 0.19% 76
2024
Q3 		$941K Buy
8,290
+664
+9% +$78.9K 0.26% 66
2024
Q2 		$944K Sell
7,626
-65
-0.8% -$8.37K 0.27% 62
2024
Q1 		$1.01M Buy
7,691
+55
+0.7% +$6.78K 0.27% 58
2023
Q4 		$832K Buy
7,636
+963
+14% +$100K 0.24% 59
2023
Q3 		$687K Buy
6,673
+389
+6% +$41.9K 0.27% 53
2023
Q2 		$725K Sell
6,284
-1,106
-15% -$126K 0.29% 53
2023
Q1 		$786K Buy
7,390
+496
+7% +$53.6K 0.34% 48
2022
Q4 		$765K Sell
6,894
-162
-2% -$16.6K 0.29% 43
2022
Q3 		$608K Sell
7,056
-103
-1% -$9.2K 0.25% 51
2022
Q2 		$653K Sell
7,159
-747
-9% -$66.2K 0.27% 51
2022
Q1 		$649K Buy
7,906
+651
+9% +$51.3K 0.24% 65
2021
Q4 		$573K Sell
7,255
-7,399
-50% -$589K 0.23% 67
2021
Q3 		$1.1M Buy
14,654
+3,402
+30% +$259K 0.51% 40
2021
Q2 		$875K Buy
11,252
+4,371
+64% +$325K 0.42% 43
2021
Q1 		$506K Buy
6,881
+690
+11% +$50.9K 0.3% 45
2020
Q4 		$478K Sell
6,191
-1,323
-18% -$101K 0.34% 40
2020
Q3 		$595K Buy
7,514
+569
+8% +$44.6K 0.51% 26
2020
Q2 		$512K Buy
6,945
+2,971
+75% +$224K 0.48% 29
2020
Q1 		$292K Buy
+3,974
New +$312K 0.36% 34

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Crumly & Associates's MRK Position: Q2 2026 in Review

Crumly & Associates increased its Merck (MRK) stake by 28% in Q2 2026, buying an estimated $233K and bringing the position to 9,224 shares worth $1.19M. The position accounts for 0.23% of the portfolio, ranked #67.

Crumly & Associates first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 1,784 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crumly & Associates held 9,224 shares of Merck worth $1.19M as of Q2 2026.
  • Crumly & Associates bought 1,993 Merck shares in Q2 2026, an estimated $233K.
  • Merck made up 0.23% of Crumly & Associates's portfolio in Q2 2026, its #67 holding.
  • Crumly & Associates first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 1,784 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.